Home » Newsletters » BioWorld Asia

BioWorld Asia

July 22, 1998

View Archived Issues

British Biotech's Woes Deepen With Increased Fiscal '98 Losses

Meconium-Related Lung Damage In Infants Linked To IL-8

Micromet Drug To Enter Trials Against Micrometastatic Cancer

Biotech To Launch Diagnostic Firm In US With A$30M

Faulding, Government Agency Develop Drug-Delivery Vehicles

Biota Sees Relenza Launch Bringing Profits In Three Years

Supratek, McGill HIV Drug May Pack Double Wallop

Alzheimer's Drug Displays Dual Action, Positive Results

Theratechnologies To Start Photodynamic Purging Trials

Investors Keep Close Watch On Progen's Cancer Treatment

EC Officials Pushing To Rally Support For Biotechnology

Biotech Incubator Being Formed In Cambridge For 12 Start-Ups

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...